Related Experiment Video
Updated: Jun 12, 2026

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
Modeling Midbrain and Brainstem Neuromelanins to Characterize Metal Binding and Associated MRI Contrast in
Niklas Wallstein1, Andrea Capucciati2,3, Andreas Pöppl4
1NMR Methods & Development Group, Max Planck Institute for Human Cognitive and Brain Sciences, Stephanstraße 1A, 04103, Leipzig, Germany.
Abstract:
Neuromelanin (NM) is a dark pigment that binds potentially toxic metal ions and is crucial for neuronal vulnerability. Magnetic resonance imaging (MRI) was proposed to measure neuromelanin in the substantia nigra or locus coeruleus, potentially providing a marker of Parkinson's disease. Here, synthetic neuromelanin analogues were prepared with iron and copper and used for characterization of metal binding and impact on proton relaxation, a prerequisite for optimizing neuromelanin-sensitive MRI. The results confirm the presence of paramagnetic mononuclear Fe(III) and antiferromagnetically coupled clusters, which enhance relaxation to variable degrees. Further complexity arises from Cu(II), which can compete for binding to mononuclear sites, aggregate in mixed-metal clusters, or bind to proteins associated with the melanin moiety. Unlike the strong relaxant Fe(III), Cu(II) only indirectly impacts relaxation by replacing iron. Overall, MRI primarily provides measures of average neuromelanin concentrations. Information on the distribution of neuromelanins with different metal compositions might be obtained with multiparametric MRI.
More Related Videos
Related Concept Videos
Magnetic Resonance Imaging
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).

